Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 May;17(4):1478-87.
doi: 10.1007/s10461-013-0463-7.

Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men

Jeffrey T Parsons  1 , William J Kowalczyk, Michael Botsko, Julia Tomassilli, Sarit A Golub
Affiliations
Comparative Study

Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men

Jeffrey T Parsons et al. AIDS Behav. 2013 May.

Abstract

Methamphetamine use is associated with HIV infection, especially among gay and bisexual men. Methamphetamine use contributes to disease progression both directly, by increasing viral load and damaging the immune system, and indirectly, by decreasing medication adherence. Research examining the association of methamphetamine use and non-adherence has traditionally compared groups of users and nonusers on adherence, compared methamphetamine use between participants above or below some threshold level of adherence (e.g. >90 % dose adherence), or examined aggregate relationships. Using Timeline Follow-back procedures, the present study examined aggregate, threshold, and day-level associations of methamphetamine use with non-adherence in 210 HIV-positive gay and bisexual methamphetamine-using men. Methamphetamine use was not associated with adherence behavior at the aggregate-level, but methamphetamine use on a given day was associated with 2.3 times the odds of non-adherence on that day. Threshold results were equivocal. These data suggest that the methamphetamine and non-adherence relationship is complicated: non-adherence is more likely to occur on days in which methamphetamine is used, but participants reported more non-adherence days in which methamphetamine was not used. This seeming paradox generates questions about the selection of analytical techniques and has important implications for behavioral interventions targeting substance use and adherence among HIV-positive individuals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparing Day-Level and Aggregate-Level Data formula image = Methamphetamine Use day formula image = HIV Medication Non-Adherence day formula image = Co-occurence of Methamphetamine Use and Non-Adherence day
See this image and copyright information in PMC

References

    1. Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J. Evolution of HIV dementia with HIV infection. International Review of Psychiatry. 2008 Feb;20(1):25–31. - PubMed
    1. HPTN-052. HIV Prevention Trials Network. 2011. Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052)
    1. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I. Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav. 2006;10(2):185–90. - PubMed
    1. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009 Jul 17;23(11):1397–404. - PubMed
    1. Montaner JS. Treatment as prevention--a double hat-trick. Lancet. 2011 Jul 16;378(9787):208–9. - PubMed

Publication types

MeSH terms

LinkOut - more resources